Stock Groups

FDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine booster By Reuters


© Reuters. FILEPHOTO: Vera Maria Soditt (family doctor) vaccinated her patient with Pfizer/BioNTech COVID-19 vaccine. It was administered in Cologne, Germany on March 28, 2021. REUTERS/Thilo Schmuelgen

(Reuters) – A panel of outside advisers to the U.S. Food and Drug Administration on Friday voted against approval of a booster dose of the Pfizer (NYSE:) Inc/BioNTech SE COVID-19 vaccine for people aged 16 and older.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. CFDs include futures, stocks, indexes and Forex. Prices are provided not by the exchanges. They are provided by market makers. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.